Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijay Modur

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Clinical Chemistry|October 5, 2012
Evidence-based laboratory medicine in oncology drug development: from biomarkers to diagnosticsVijay Modur, Eric Hailman, J C Barrett
Cellular Signalling|January 9, 2020
Glycosphingolipid metabolism and polycystic kidney diseaseThomas A Natoli, Vijay Modur, Oxana Ibraghimov-Beskrovnaya
Clinical Chemistry|September 27, 2015
Biomarkers in Pharmaceutical ResearchXuemei Zhao, Vijay Modur, Leonidas N Carayannopoulos, et al.
Circulation|May 4, 2005
Enrichment of genes in the aortic intima that are associated with stratified epithelium: implications of underlying biomechanical and barrier properties of the arterial intimaPampee P Young, Vijay Modur, Amylynn A Teleron, et al.
Molecular Genetics and Metabolism Reports|December 13, 2021
Fabry Disease Patient-Reported Outcome (FD-PRO) demonstrates robust measurement properties for assessing symptom severity in Fabry diseaseAlaa Hamed, Pronabesh DasMahapatra, Nicole Lyn, et al.
Molecular Genetics & Genomic Medicine|November 17, 2025
Historical Control Analysis Demonstrates Greater Long-Term Reduction in Plasma Globotriaosylceramide (Gb3) by Venglustat Compared With Placebo or Agalsidase Beta in Male Patients With Classic Fabry DiseaseDominique P Germain, Pronabesh DasMahapatra, Shiguang Liu, et al.
Clinical Chemistry|August 16, 2008
The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patientsJin-Moo Lee, Kaj Blennow, Niels Andreasen, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 22, 2023
Novel read through agent: ZKN-0013 demonstrates efficacy in APC<sup>min</sup> model of familial adenomatous polyposisMartin R Graf, Shruti Apte, Esteban Terzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2011
BCR-ABL transcript dynamics support the hypothesis that leukemic stem cells are reduced during imatinib treatmentAndrew M Stein, Dean Bottino, Vijay Modur, et al.
Cancer Research Communications|June 28, 2023
A Novel Class of Ribosome Modulating Agents Exploits Cancer Ribosome Heterogeneity to Selectively Target the CMS2 Subtype of Colorectal CancerEsteban Terzo, Shruti A Apte, Simran Padhye, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinical Chemistry|October 5, 2012
Evidence-based laboratory medicine in oncology drug development: from biomarkers to diagnosticsVijay Modur, Eric Hailman, J C Barrett
Cellular Signalling|January 9, 2020
Glycosphingolipid metabolism and polycystic kidney diseaseThomas A Natoli, Vijay Modur, Oxana Ibraghimov-Beskrovnaya
Clinical Chemistry|September 27, 2015
Biomarkers in Pharmaceutical ResearchXuemei Zhao, Vijay Modur, Leonidas N Carayannopoulos, et al.
Circulation|May 4, 2005
Enrichment of genes in the aortic intima that are associated with stratified epithelium: implications of underlying biomechanical and barrier properties of the arterial intimaPampee P Young, Vijay Modur, Amylynn A Teleron, et al.
Molecular Genetics and Metabolism Reports|December 13, 2021
Fabry Disease Patient-Reported Outcome (FD-PRO) demonstrates robust measurement properties for assessing symptom severity in Fabry diseaseAlaa Hamed, Pronabesh DasMahapatra, Nicole Lyn, et al.
Molecular Genetics & Genomic Medicine|November 17, 2025
Historical Control Analysis Demonstrates Greater Long-Term Reduction in Plasma Globotriaosylceramide (Gb3) by Venglustat Compared With Placebo or Agalsidase Beta in Male Patients With Classic Fabry DiseaseDominique P Germain, Pronabesh DasMahapatra, Shiguang Liu, et al.
Clinical Chemistry|August 16, 2008
The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patientsJin-Moo Lee, Kaj Blennow, Niels Andreasen, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 22, 2023
Novel read through agent: ZKN-0013 demonstrates efficacy in APC<sup>min</sup> model of familial adenomatous polyposisMartin R Graf, Shruti Apte, Esteban Terzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2011
BCR-ABL transcript dynamics support the hypothesis that leukemic stem cells are reduced during imatinib treatmentAndrew M Stein, Dean Bottino, Vijay Modur, et al.
Cancer Research Communications|June 28, 2023
A Novel Class of Ribosome Modulating Agents Exploits Cancer Ribosome Heterogeneity to Selectively Target the CMS2 Subtype of Colorectal CancerEsteban Terzo, Shruti A Apte, Simran Padhye, et al.
Pageof 3